AMZN
Amazon.com, Inc.
AMZN has the edge over DLTH overall, supported by stronger valuation and stronger modeled upside.
DLTH
Duluth Holdings Inc.
DLTH offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
DLTH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
DLTH's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over DLTH in the historical PE scenario, which offers more potential upside but is not a forecast.
DLTH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 13x | $1.88 | -52% |
| Fair | 18x | $2.66 | -32% |
| Current | 26x | $3.90 | — |
| Expensive | 29x | $4.40 | +13% |
Historical ranges are pointers, not guarantees.
DLTH's PE is in its expensive range at 26x.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over DLTH on the outlook, with more favorable revenue expectations.
DLTH Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect DLTH's losses to shrink, with revenue holding steady.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over DLTH on earnings, with more consistent year-over-year improvement.
DLTH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.15 | +$1.52 |
| Q2 2026 | -$0.31 | +$1.21 |
| Q1 2026 | -$0.47 | +$0.84 |
| Q4 2025 | -$0.81 | +$0.17 |
| Q3 2025 | -$1.37 | -$0.92 |
| Q2 2025 | -$1.52 | -$1.12 |
| Q1 2025 | -$1.31 | -$1.03 |
| Q4 2024 | -$0.98 | -$0.71 |
DLTH has returned to profit: it earned $0.15 per share over the past year, after losing money the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over DLTH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN's operating margin was 14% last quarter, up 4.2 points from the same quarter a year ago, near the top of its range since 2019.
DLTH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $121.4M | -7.8% |
| Q2 2026 | $98.6M | -4% |
| Q1 2026 | $215.9M | -11% |
| Q4 2025 | $114.9M | -9.6% |
| Q3 2025 | $131.7M | -7% |
| Q2 2025 | $102.7M | -12% |
| Q1 2025 | $241.3M | -1.8% |
| Q4 2024 | $127.1M | -8.1% |
DLTH's revenue has slid since its 2022 peak: $121M last quarter, down 7.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 16% | +14 points |
| Q2 2026 | -9.4% | +2.7 points |
| Q1 2026 | 4% | +4.6 points |
| Q4 2025 | -7.7% | +10 points |
| Q3 2025 | 1.8% | +4.6 points |
| Q2 2025 | -12% | -4.3 points |
| Q1 2025 | -0.6% | -4.5 points |
| Q4 2024 | -18% | -8.8 points |
DLTH has the edge over AMZN on profitability, with a higher operating margin.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
DLTH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $28.2M | -5.5% |
| Q2 2026 | -$15.2M | +$42.6M |
| Q1 2026 | $53.5M | +38% |
| Q4 2025 | -$8.9M | +$34.8M |
| Q3 2025 | $29.8M | +99% |
| Q2 2025 | -$57.8M | -$22.6M |
| Q1 2025 | $38.7M | -36% |
| Q4 2024 | -$43.7M | -$5.5M |
DLTH has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over DLTH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
DLTH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.8% | +1.7M shares |
| 1 year | +5% | +1.7M shares |
| 3 years | +10% | +3.4M shares |
| 5 years | +11% | +3.6M shares |
| Available history | +13% | +4.1M shares |
DLTH has 36M diluted shares, up 5% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2020 | $1,000 |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
DLTH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | -1.0x | Net Cash |
| Q4 2025 | 5.4x | High |
| Q4 2024 | 4.7x | High |
| Q3 2024 | -0.5x | Net Cash |
| Q2 2024 | 0.3x | Very low |
| Q1 2024 | -1.3x | Net Cash |
DLTH has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
DLTH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.2 | Neutral |
| Stochastic | 44.2 | Neutral |
DLTH's weekly RSI is 50 (neutral) and its Stochastic is 44 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over DLTH on valuation relative to its sector.
DLTH PE vs Consumer Cyclical Sector
| Metric | DLTH | Sector median | Relative |
|---|---|---|---|
| PE | 26x | 18x | 44% above |
| PE % | 73 | 47 | 26 pts above |
DLTH is trading at 26x earnings, a 44% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over DLTH on trend strength, trading above more of its moving averages.
DLTH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.99 | 2.3% below |
| 20 week MA | $4.11 | 5.1% below |
| 50 week MA | $3.40 | 15% above |
| 100 week MA | $2.98 | 31% above |
| 200 week MA | $4.03 | 3.2% below |
DLTH's trend is mixed: it's above two of its five weekly moving averages, and 3.2% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
DLTH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.3 | $11.2 | +8.6% |
| 2021 | $11.2 | $15.1 | +35% |
| 2022 | $15.1 | $5.90 | -61% |
| 2023 | $5.90 | $5.38 | -8.8% |
| 2024 | $5.38 | $3.03 | -44% |
| 2025 | $3.03 | $2.11 | -30% |
| 2026 YTD | $2.11 | $3.90 | +85% |
DLTH has the edge over AMZN on returns for 2026, with the stronger performance.